| Literature DB >> 17621798 |
J Wollenhaupt1, R Alten, H Burkhardt, E Edelmann, E Gromnica-Ihle, A Krause, K Krüger, B Manger, H Lorenz, U Müller-Ladner, H Nüsslein, H G Pott, H Tony, M Schneider.
Abstract
The success of the treatment of rheumatoid arthritis depends primarily on early diagnosis. In most cases, basic therapy begins with methotrexate. Depending on the stage and course of the disease (radiographically detected early erosion and/or progression), basic immunosuppressive therapy can be combined or supplemented with cytokine antagonists. Furthermore, for specific indications, several alternative active substances (DMARD monotherapies) are available. Today the goal of therapy is always remission.Entities:
Mesh:
Substances:
Year: 2006 PMID: 17621798
Source DB: PubMed Journal: MMW Fortschr Med ISSN: 1438-3276